ShockWave Medical, Inc. SWAV NASDAQ

ShockWave Medical, Inc. (SWAV) trades at a trailing P/E of 87.0, forward P/E of 46.5. Trailing earnings yield is 1.15%, forward earnings yield 2.15%. PEG 0.53 (Peter Lynch undervalued ≤1.0).

Criteria proven by this page:

• VALUE (12/100, Fail) — trailing P/E is well above the S&P 500 average of ~25, suggesting a premium valuation (P/E 87.0); analyst consensus target implies downside from the current price ($258.17, 22.9%).
• Forward P/E 46.5 (down from trailing 87.0) — analysts expect earnings to grow, which would improve the valuation.
• PEG Ratio 0.53 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
• Trailing Earnings Yield 1.15% — below bond yields — investors are paying a premium for expected growth rather than current earnings. Forward yield improves to 2.15% as earnings recover.
• Analyst consensus target $258.17 (-22.9% downside) — analysts see meaningful downside risk at the current price level.

Overall SharesGrow Score: 60/100 with 4/7 criteria passed.